NanoAntibiotics CEO Says His Firm Is Poised For Growth In Biotech's Potent Liver Disease Treatment Space

Emerging small cap firm is pioneering CIPT Technology as a potential breakthrough for the treatment of ascites, a life-threatening complication of advanced liver cirrhosis.